2OEF
Open and Closed Structures of the UDP-Glucose Pyrophosphorylase from Leishmania major
Summary for 2OEF
Entry DOI | 10.2210/pdb2oef/pdb |
Descriptor | UTP-glucose-1-phosphate uridylyltransferase 2, putative, SULFATE ION (3 entities in total) |
Functional Keywords | rossmann-fold, beta-helix, pyrophosphorylase, transferase |
Biological source | Leishmania major |
Total number of polymer chains | 1 |
Total formula weight | 57137.91 |
Authors | Steiner, T. (deposition date: 2006-12-29, release date: 2007-02-13, Last modification date: 2024-11-13) |
Primary citation | Steiner, T.,Lamerz, A.C.,Hess, P.,Breithaupt, C.,Krapp, S.,Bourenkov, G.,Huber, R.,Gerardy-Schahn, R.,Jacob, U. Open and Closed Structures of the UDP-glucose Pyrophosphorylase from Leishmania major. J.Biol.Chem., 282:13003-13010, 2007 Cited by PubMed Abstract: Uridine diphosphate-glucose pyrophosphorylase (UGPase) represents a ubiquitous enzyme, which catalyzes the formation of UDP-glucose, a key metabolite of the carbohydrate pathways of all organisms. In the protozoan parasite Leishmania major, which causes a broad spectrum of diseases and is transmitted to humans by sand fly vectors, UGPase represents a virulence factor because of its requirement for the synthesis of cell surface glycoconjugates. Here we present the crystal structures of the L. major UGPase in its uncomplexed apo form (open conformation) and in complex with UDP-glucose (closed conformation). The UGPase consists of three distinct domains. The N-terminal domain exhibits species-specific differences in length, which might permit distinct regulation mechanisms. The central catalytic domain resembles a Rossmann-fold and contains key residues that are conserved in many nucleotidyltransferases. The C-terminal domain forms a left-handed parallel beta-helix (LbetaH), which represents a rarely observed structural element. The presented structures together with mutagenesis analyses provide a basis for a detailed analysis of the catalytic mechanism and for the design of species-specific UGPase inhibitors. PubMed: 17303565DOI: 10.1074/jbc.M609984200 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.4 Å) |
Structure validation
Download full validation report
